Evidence map›Paper›PMID 24260200›Full record

ArticlePloS one2013

CRF2 signaling is a novel regulator of cellular adhesion and migration in colorectal cancer cells.

Benjamin Ducarouge, Marjolaine Pelissier-Rota, Michèle Lainé, Nadine Cristina, Yvan Vachez, Jean-Yves Scoazec, Bruno Bonaz, Muriel Jacquier-Sarlin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. CRFFrontiers in endocrinology · 2019
    Article
  5. Article
  6. Article
  7. Involvement of CRF2 signaling in enterocyte differentiation.World journal of gastroenterology · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Benjamin DucarougeEquipe du Stress et des Interactions Neurodigestives, INSERM U836, Grenoble, France ; Université Joseph Fourier, Grenoble Institut des Neurosciences, Grenoble, France.
Marjolaine Pelissier-Rota
Michèle Lainé
Nadine Cristina
Yvan Vachez
Jean-Yves Scoazec
Bruno Bonaz
Muriel Jacquier-Sarlin
Inserm · FRUniversité Joseph Fourier · FRHôpital Edouard Herriot · FRUniversité Grenoble Alpes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress has been proposed to be a tumor promoting factor through the secretion of specific neuromediators, such as Urocortin2 and 3 (Ucn2/3), however its role in colorectal cancer (CRC) remains elusive. We observed that Ucn2/3 and their receptor the Corticotropin Releasing Factor receptor 2 (CRF2) were up-regulated in high grade and poorly differentiated CRC. This suggests a role for CRF2 in the loss of cellular organization and tumor progression. Using HT-29 and SW620 cells, two CRC cell lines differing in their abilities to perform cell-cell contacts, we found that CRF2 signals through Src/ERK pathway to induce the alteration of cell-cell junctions and the shuttle of p120ctn and Kaiso in the nucleus. In HT-29 cells, this signaling pathway also leads to the remodeling of cell adhesion by i) the phosphorylation of Focal Adhesion Kinase and ii) a modification of actin cytoskeleton and focal adhesion complexes. These events stimulate cell migration and invasion. In conclusion, our findings indicate that CRF2 signaling controls cellular organization and may promote metastatic potential of human CRC cells through an epithelial-mesenchymal transition like process. This contributes to the comprehension of the tumor-promoting effects of stress molecules and designates Ucn2/3-CRF2 tandem as a target to prevent CRC progression and aggressiveness.

Indexed as

Cell AdhesionCell LineCell MovementColorectal NeoplasmsEpithelial-Mesenchymal TransitionHT29 CellsHumansImmunoblottingImmunohistochemistryImmunoprecipitationPolymerase Chain ReactionReceptors, Corticotropin-Releasing HormoneSignal TransductionCRF receptor type 2Receptors, Corticotropin-Releasing Hormone

Identifiers

PMID24260200
PMCPMC3832608
OpenAlexW2032688548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.